array:23 [
  "pii" => "S2341287921000120"
  "issn" => "23412879"
  "doi" => "10.1016/j.anpede.2020.12.007"
  "estado" => "S300"
  "fechaPublicacion" => "2021-03-01"
  "aid" => "3065"
  "copyrightAnyo" => "2021"
  "documento" => "article"
  "crossmark" => 1
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "sco"
  "cita" => "An Pediatr (Barc). 2021;94:127-8"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:1 [
    "total" => 0
  ]
  "Traduccion" => array:1 [
    "en" => array:19 [
      "pii" => "S1695403320305300"
      "issn" => "16954033"
      "doi" => "10.1016/j.anpedi.2020.12.011"
      "estado" => "S300"
      "fechaPublicacion" => "2021-03-01"
      "aid" => "3065"
      "documento" => "article"
      "crossmark" => 1
      "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
      "subdocumento" => "sco"
      "cita" => "An Pediatr (Barc). 2021;94:127-8"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:1 [
        "total" => 0
      ]
      "en" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">EDITORIAL</span>"
        "titulo" => "Medicamentos <span class="elsevierStyleItalic">off-label</span> y <span class="elsevierStyleItalic">sin licencia</span> en neonatolog&#237;a"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "127"
            "paginaFinal" => "128"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "<span class="elsevierStyleItalic">Off-label</span> and <span class="elsevierStyleItalic">unlicensed</span> drugs in neonatology"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Segundo Rite-Gracia, Alejandro Avila-Alvarez"
            "autores" => array:2 [
              0 => array:2 [
                "nombre" => "Segundo"
                "apellidos" => "Rite-Gracia"
              ]
              1 => array:2 [
                "nombre" => "Alejandro"
                "apellidos" => "Avila-Alvarez"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S2341287921000120"
          "doi" => "10.1016/j.anpede.2020.12.007"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341287921000120?idApp=UINPBA00005H"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1695403320305300?idApp=UINPBA00005H"
      "url" => "/16954033/0000009400000003/v1_202103020707/S1695403320305300/v1_202103020707/en/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S2341287921000107"
    "issn" => "23412879"
    "doi" => "10.1016/j.anpede.2020.03.015"
    "estado" => "S300"
    "fechaPublicacion" => "2021-03-01"
    "aid" => "2826"
    "documento" => "article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "fla"
    "cita" => "An Pediatr &#40;Barc&#41;. 2021;94:129-35"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>"
      "titulo" => "The chest <span class="elsevierStyleSmallCaps">x</span>-ray in acute bronchiolitis&#58; technical quality&#44; findings&#44; and an assessment of its reliability"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "129"
          "paginaFinal" => "135"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "La radiograf&#237;a de t&#243;rax en la bronquiolitis aguda&#58; calidad t&#233;cnica&#44; hallazgos y evaluaci&#243;n de su fiabilidad"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:8 [
          "identificador" => "fig0005"
          "etiqueta" => "Figure 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1775
              "Ancho" => 3285
              "Tamanyo" => 226288
            ]
          ]
          "detalles" => array:1 [
            0 => array:3 [
              "identificador" => "at0005"
              "detalle" => "Figure "
              "rol" => "short"
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Evaluation by the radiologist of the presence of the different radiographic signs&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Juan Manuel Rius Peris, Ana Isabel Mara&#241;a P&#233;rez, Ana Valiente Armero, Jorge Mateo Sotos, Leonor Guardia Nieto, Ana Mar&#237;a Torres, Elisa Mar&#237;a Cueto Calvo"
          "autores" => array:7 [
            0 => array:2 [
              "nombre" => "Juan Manuel"
              "apellidos" => "Rius Peris"
            ]
            1 => array:2 [
              "nombre" => "Ana Isabel"
              "apellidos" => "Mara&#241;a P&#233;rez"
            ]
            2 => array:2 [
              "nombre" => "Ana"
              "apellidos" => "Valiente Armero"
            ]
            3 => array:2 [
              "nombre" => "Jorge"
              "apellidos" => "Mateo Sotos"
            ]
            4 => array:2 [
              "nombre" => "Leonor"
              "apellidos" => "Guardia Nieto"
            ]
            5 => array:2 [
              "nombre" => "Ana"
              "apellidos" => "Mar&#237;a Torres"
            ]
            6 => array:2 [
              "nombre" => "Elisa Mar&#237;a"
              "apellidos" => "Cueto Calvo"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S1695403320301405"
        "doi" => "10.1016/j.anpedi.2020.03.011"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1695403320301405?idApp=UINPBA00005H"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341287921000107?idApp=UINPBA00005H"
    "url" => "/23412879/0000009400000003/v1_202103020834/S2341287921000107/v1_202103020834/en/main.assets"
  ]
  "en" => array:12 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>"
    "titulo" => "Off-label and unlicensed drugs in neonatology"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "127"
        "paginaFinal" => "128"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Segundo Rite-Gracia, Alejandro &#193;vila-&#193;lvarez"
        "autores" => array:2 [
          0 => array:4 [
            "nombre" => "Segundo"
            "apellidos" => "Rite-Gracia"
            "email" => array:1 [
              0 => "sriteg@salud.aragon.es"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "&#42;"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "Alejandro"
            "apellidos" => "&#193;vila-&#193;lvarez"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:2 [
          0 => array:3 [
            "entidad" => "Unidad de Neonatolog&#237;a&#44; Servicio de Pediatr&#237;a&#44; Hospital Universitario Miguel Servet&#44; Zaragoza&#44; Espa&#241;a"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Unidad de Neonatolog&#237;a&#44; Servicio de Pediatr&#237;a&#44; Complexo Hospitalario Universitario de A Coru&#241;a &#40;CHUAC&#41;&#44; Sergas&#44; A Coru&#241;a&#44; Espa&#241;a"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Medicamentos off-label y sin licencia en neonatolog&#237;a"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">At present&#44; a significant proportion of neonates admitted to neonatal intensive care units &#40;NICUs&#41; receive off-label or unlicensed drugs&#44; mainly due to the scarcity of evidence on drug efficacy and safety in the neonatal period&#46; In Spain&#44; a recent study in a level IIIC NICU conducted by Sucasas-Alonso et al&#46; found that 22&#46;5&#37; of prescriptions were off-label and 8&#37; unlicensed&#44; and that as many as 59&#46;5&#37; of the patients received at least one prescription under one of these conditions&#46;<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Unlicensed</span> refers to use of unauthorised drugs&#44; drugs contraindicated in the neonatal period&#44; imported drugs or formulations compounded in the pharmacy&#44; the latter of which account for a large part of the variability of unlicensed drug prescription found between studies conducted in different countries&#46; <span class="elsevierStyleItalic">Off-label</span> refers to the use of authorised drugs under conditions other than those detailed in the summary of product characteristics approved by the competent regulatory agent in terms of age&#44; indication&#44; dosage&#44; interval between doses or the route of administration&#46; The substantial variability in off-label prescription is due to the criterion used to define it&#59; thus&#44; Gei&#223;ler et al&#46; reported a proportion of off-label prescription of 39&#46;2&#37; in one NICU in 2014 considering exclusively the age criterion&#44;<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> whereas a multicentre study conducted in Italy by Cuzzolin and Agostino found a proportion of off-label prescription of 59&#46;5&#37; over the total prescriptions taking into account criteria in addition to age&#44; such as the indication&#44; dose&#44; dose schedule&#44; route of administration and duration of treatment&#46;<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> In a study published in the current issue of <span class="elsevierStyleSmallCaps">Anales de Pediatr&#237;a</span>&#44; Lima-Costa et al&#46; analysed off-label and unlabelled prescriptions in a NICU in Brazil based on the criteria established by 2 agencies&#58; the National Health Surveillance Agency &#40;ANVISA&#41; of Brazil and the Food and Drug Administration &#40;FDA&#41; of the United States&#46;<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> They found a higher frequency of unlicensed prescription with the application of the FDA criteria &#40;24&#46;6 vs 17&#46;2&#37;&#59; <span class="elsevierStyleItalic">P</span>&#8239;<span class="elsevierStyleItalic">&#60;</span>&#8239;&#46;01&#41;&#46; However&#44; when it came to off-label prescription&#44; the frequency was lower applying the criteria of the FDA &#40;49&#46;3 vs 52&#46;6&#59; <span class="elsevierStyleItalic">P</span>&#8239;<span class="elsevierStyleItalic">&#60;</span>&#8239;&#46;01&#41;&#44; as this agency is more specific in regard to the ages and indications for which use is authorised&#46; The agreement analysis found the greatest disparities in age and indication criteria&#44; especially for drugs acting on the cardiovascular system and the central nervous system&#46; This study contributes new evidence on the issue of unapproved drug prescription in neonatology&#46;</p><p id="par0015" class="elsevierStylePara elsevierViewall">Pharmacological treatment in neonates is affected by the immaturity of the hepatic clearance systems and renal function in this population&#44; which differs from other age groups not only in pharmacokinetics&#44; but also in pharmacodynamics&#46; This is particularly relevant in the NICU setting due to the underlying conditions that affect critically ill neonates and the high proportion of patients born preterm or small for gestational age&#46; Thus&#44; more paediatric and neonatal studies are required to achieve a reduction in off-label and unlicensed prescription&#46; This was the main objective of the legislation introduced in the European Union in 2007&#58; to reduce the use of off-label drugs in the paediatric age group and to increase the clinical evidence in this population to improve the safety of pharmacotherapy&#46; Some of the measures adopted to this end were the extension of patents for paediatric drugs and the establishment of public funding programmes to facilitate research outside the pharmaceutical industry&#46; However&#44; as the study by Gei&#223;ler et al&#46; demonstrates&#44; there were no changes in the patterns of off-label prescription between 2004 and 2014 associated with the legislation introduced in the European Union in 2007&#44; of which a very clear example is the fact that despite changes in regulation&#44; 100&#37; of neonates born preterm before 28 weeks&#8217; gestation received at least 1 off-label or unlicensed drug&#46;<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> The number of drugs licensed for use in newborns continues to be small&#44; for while European law mandates that trials include this population in the authorization process for any new drugs&#44; this obligation does not extend to drugs that are already marketed to which&#44; consequently&#44; the protection of the patent does not apply&#44; providing little incentive for pharmaceutical companies to change the situation&#44; as future profits would be relatively small relative to the costs of the research that would be required&#46;</p><p id="par0020" class="elsevierStylePara elsevierViewall">In the current issue of <span class="elsevierStyleSmallCaps">Anales de Pediatr&#237;a</span>&#44; Pi&#241;eiro P&#233;rez et al&#46;&#44; on behalf of the Committee on Medicines of the Asociaci&#243;n Espa&#241;ola de Pediatr&#237;a &#40;Spanish Association of Pediatrics&#44; AEP&#41;&#44; reflect on some of the theoretical&#44; legal and practical aspects of unapproved prescription in paediatrics&#46; We believe that the concise yet rigorous exposition by the authors&#44; in the form of questions and answers&#44; will contribute to a clearer understanding to the very important subject of drug prescription in paediatrics&#44; particularly in neonatal care and neonatal intensive care units&#46;<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">The fact that some drugs go from being considered off-label to being authorised and vice versa evinces that authorization does not necessarily imply that more evidence is available on those drugs&#46; This is particularly evident in older drugs&#44; for which fewer requirements needed to be met for authorization compared to current requirements&#46; In any case&#44; it is obvious that off-label prescription is neither illegal nor inappropriate and is often a decision based on years of clinical experience and a lack of alternative drugs stemming from the low availability of adequate drugs currently licensed&#46; Nevertheless&#44; this carries an increased risk for neonates&#44; as evinced by the higher frequency of adverse drug reactions and medication errors in this age group&#46;</p><p id="par0030" class="elsevierStylePara elsevierViewall">The number of off-label prescriptions becomes significantly smaller if the criteria used to define them includes&#44; in addition to those of regulatory agencies&#44; the criteria of other databases&#44; such as the databases available in Spain in the field of paediatrics &#40;<span class="elsevierStyleItalic">Pediam&#233;cum</span>&#44; launched by the Committee on Medicines of the AEP in 2012&#41; or for the general population &#40;<span class="elsevierStyleItalic">Bot Plus</span>&#44; created by the General Council of Boards of Pharmacy of Spain&#41;&#44; which provide standardised and updated information on medicines&#46; Similarly&#44; Cuzzolin and Agostino showed that taking as reference the guidelines developed by the Neonatal Pharmacotherapy Study Group of the Italian Society of Neonatology&#44; only one fourth of prescriptions deviated from the recommendations&#44; compared to a proportion of off-label or unlicensed prescription of 73&#46;5&#37; based on the criteria of regulatory agencies&#46;<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> This demonstrates that there is a marked discrepancy between the general indications included in the summary of product characteristics and the recommendations given taking into account patient characteristics and indications&#46; In neonatal care&#44; this is particularly frequent in antimicrobial prescription&#46;</p><p id="par0035" class="elsevierStylePara elsevierViewall">In our opinion&#44; the solution of this problem requires the development of policies providing incentives for research in the neonatal age group&#46; However&#44; while we await further and improved evidence allowing a reduction in unapproved drug prescription&#44; efforts should be made to achieve greater homogeneity in the information available on pharmacological agents used in the neonatal population&#46;</p></span>"
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0030">Please cite this article as&#58; &#193;vila-&#193;lvarez A&#46; Medicamentos off-label y sin licencia en neonatolog&#237;a&#46; An Pediatr &#40;Barc&#41;&#46; 2021&#59;94&#58;127&#8211;128&#46;</p>"
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:5 [
            0 => array:3 [
              "identificador" => "bib0005"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Uso de medicamentos en condiciones no aprobadas en cuidados intensivos neonatales"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46; Sucasas-Alonso"
                            1 => "A&#46; &#193;vila-&#193;lvarez"
                            2 => "M&#46; Combarro-Eiriz"
                            3 => "C&#46; Mart&#237;nez-Roca"
                            4 => "P&#46; Y&#225;&#241;ez-G&#243;mez"
                            5 => "A&#46; Codias-L&#243;pez"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "An Pediatr &#40;Barc&#41;"
                        "fecha" => "2019"
                        "volumen" => "91"
                        "paginaInicial" => "237"
                        "paginaFinal" => "243"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0010"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Drug utilization and off-label use on a German Neonatal Intensive Care Unit&#58; A retrospective cohort study and 10-year comparison"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "C&#46; Gei&#223;ler"
                            1 => "C&#46; Schulze"
                            2 => "S&#46; Botzenhartdt"
                            3 => "W&#46; Rascher"
                            4 => "A&#46; Neubert"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "tituloSerie" => "Pharmacy &#40;Basel&#41;"
                        "fecha" => "2020"
                        "volumen" => "8"
                        "paginaInicial" => "173"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0015"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Off-label and unlicensed drug treatments in Neonatal Intensive Care Units&#58; an Italian multicentre study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "L&#46; Cuzzolin"
                            1 => "R&#46; Agostino"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s00228-015-1962-4"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur J Clin Pharmacol"
                        "fecha" => "2016"
                        "volumen" => "72"
                        "paginaInicial" => "117"
                        "paginaFinal" => "123"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26490354"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0020"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Evaluaci&#243;n comparativa de la prescripci&#243;n de medicamentos off-label y sin licencia en neonatos&#58; FDA versus directrices brasile&#241;as"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "H&#46;T&#46;M&#46; Lima-Costa"
                            1 => "P&#46;K&#46; do Vale Bezerra"
                            2 => "J&#46;E&#46; Chaves-Cavalcanti"
                            3 => "T&#46;X&#46; Costa"
                            4 => "F&#46;E&#46; Medeiros-Fernandes"
                            5 => "R&#46; Randall-Martins"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "An Pediatr &#40;Barc&#41;"
                        "fecha" => "2021"
                        "volumen" => "94"
                        "paginaInicial" => "153"
                        "paginaFinal" => "160"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0025"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Medicamentos fuera de ficha t&#233;cnica en pediatr&#237;a"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "R&#46; Pi&#241;eiro P&#233;rez"
                            1 => "E&#46; N&#250;&#241;ez Cuadros"
                            2 => "B&#46; Rodr&#237;guez Marrod&#225;n"
                            3 => "R&#46; Escrig Fern&#225;ndez"
                            4 => "M&#46;A&#46; Gil Lemus"
                            5 => "S&#46; Manzano Blanco"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "An Pediatr &#40;Barc&#41;"
                        "fecha" => "2021"
                        "volumen" => "94"
                        "paginaInicial" => "188&#46;e1"
                        "paginaFinal" => "188&#46;e9"
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/23412879/0000009400000003/v1_202103020834/S2341287921000120/v1_202103020834/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "25501"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Editorial"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/23412879/0000009400000003/v1_202103020834/S2341287921000120/v1_202103020834/en/main.pdf?idApp=UINPBA00005H&text.app=https://analesdepediatria.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341287921000120?idApp=UINPBA00005H"
]
Share
Journal Information

Statistics

Follow this link to access the full text of the article

Editorial
Off-label and unlicensed drugs in neonatology
Medicamentos off-label y sin licencia en neonatología
Segundo Rite-Graciaa,
Corresponding author
sriteg@salud.aragon.es

Corresponding author.
, Alejandro Ávila-Álvarezb
a Unidad de Neonatología, Servicio de Pediatría, Hospital Universitario Miguel Servet, Zaragoza, España
b Unidad de Neonatología, Servicio de Pediatría, Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas, A Coruña, España
Read
3441
Times
was read the article
1508
Total PDF
1933
Total HTML
Share statistics
 array:23 [
  "pii" => "S2341287921000120"
  "issn" => "23412879"
  "doi" => "10.1016/j.anpede.2020.12.007"
  "estado" => "S300"
  "fechaPublicacion" => "2021-03-01"
  "aid" => "3065"
  "copyrightAnyo" => "2021"
  "documento" => "article"
  "crossmark" => 1
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "sco"
  "cita" => "An Pediatr &#40;Barc&#41;. 2021;94:127-8"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:1 [
    "total" => 0
  ]
  "Traduccion" => array:1 [
    "en" => array:19 [
      "pii" => "S1695403320305300"
      "issn" => "16954033"
      "doi" => "10.1016/j.anpedi.2020.12.011"
      "estado" => "S300"
      "fechaPublicacion" => "2021-03-01"
      "aid" => "3065"
      "documento" => "article"
      "crossmark" => 1
      "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
      "subdocumento" => "sco"
      "cita" => "An Pediatr &#40;Barc&#41;. 2021;94:127-8"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:1 [
        "total" => 0
      ]
      "en" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">EDITORIAL</span>"
        "titulo" => "Medicamentos <span class="elsevierStyleItalic">off-label</span> y <span class="elsevierStyleItalic">sin licencia</span> en neonatolog&#237;a"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "127"
            "paginaFinal" => "128"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "<span class="elsevierStyleItalic">Off-label</span> and <span class="elsevierStyleItalic">unlicensed</span> drugs in neonatology"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Segundo Rite-Gracia, Alejandro Avila-Alvarez"
            "autores" => array:2 [
              0 => array:2 [
                "nombre" => "Segundo"
                "apellidos" => "Rite-Gracia"
              ]
              1 => array:2 [
                "nombre" => "Alejandro"
                "apellidos" => "Avila-Alvarez"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S2341287921000120"
          "doi" => "10.1016/j.anpede.2020.12.007"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341287921000120?idApp=UINPBA00005H"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1695403320305300?idApp=UINPBA00005H"
      "url" => "/16954033/0000009400000003/v1_202103020707/S1695403320305300/v1_202103020707/en/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S2341287921000107"
    "issn" => "23412879"
    "doi" => "10.1016/j.anpede.2020.03.015"
    "estado" => "S300"
    "fechaPublicacion" => "2021-03-01"
    "aid" => "2826"
    "documento" => "article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "fla"
    "cita" => "An Pediatr &#40;Barc&#41;. 2021;94:129-35"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>"
      "titulo" => "The chest <span class="elsevierStyleSmallCaps">x</span>-ray in acute bronchiolitis&#58; technical quality&#44; findings&#44; and an assessment of its reliability"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "129"
          "paginaFinal" => "135"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "La radiograf&#237;a de t&#243;rax en la bronquiolitis aguda&#58; calidad t&#233;cnica&#44; hallazgos y evaluaci&#243;n de su fiabilidad"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:8 [
          "identificador" => "fig0005"
          "etiqueta" => "Figure 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1775
              "Ancho" => 3285
              "Tamanyo" => 226288
            ]
          ]
          "detalles" => array:1 [
            0 => array:3 [
              "identificador" => "at0005"
              "detalle" => "Figure "
              "rol" => "short"
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Evaluation by the radiologist of the presence of the different radiographic signs&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Juan Manuel Rius Peris, Ana Isabel Mara&#241;a P&#233;rez, Ana Valiente Armero, Jorge Mateo Sotos, Leonor Guardia Nieto, Ana Mar&#237;a Torres, Elisa Mar&#237;a Cueto Calvo"
          "autores" => array:7 [
            0 => array:2 [
              "nombre" => "Juan Manuel"
              "apellidos" => "Rius Peris"
            ]
            1 => array:2 [
              "nombre" => "Ana Isabel"
              "apellidos" => "Mara&#241;a P&#233;rez"
            ]
            2 => array:2 [
              "nombre" => "Ana"
              "apellidos" => "Valiente Armero"
            ]
            3 => array:2 [
              "nombre" => "Jorge"
              "apellidos" => "Mateo Sotos"
            ]
            4 => array:2 [
              "nombre" => "Leonor"
              "apellidos" => "Guardia Nieto"
            ]
            5 => array:2 [
              "nombre" => "Ana"
              "apellidos" => "Mar&#237;a Torres"
            ]
            6 => array:2 [
              "nombre" => "Elisa Mar&#237;a"
              "apellidos" => "Cueto Calvo"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S1695403320301405"
        "doi" => "10.1016/j.anpedi.2020.03.011"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1695403320301405?idApp=UINPBA00005H"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341287921000107?idApp=UINPBA00005H"
    "url" => "/23412879/0000009400000003/v1_202103020834/S2341287921000107/v1_202103020834/en/main.assets"
  ]
  "en" => array:12 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>"
    "titulo" => "Off-label and unlicensed drugs in neonatology"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "127"
        "paginaFinal" => "128"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Segundo Rite-Gracia, Alejandro &#193;vila-&#193;lvarez"
        "autores" => array:2 [
          0 => array:4 [
            "nombre" => "Segundo"
            "apellidos" => "Rite-Gracia"
            "email" => array:1 [
              0 => "sriteg@salud.aragon.es"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "&#42;"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "Alejandro"
            "apellidos" => "&#193;vila-&#193;lvarez"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:2 [
          0 => array:3 [
            "entidad" => "Unidad de Neonatolog&#237;a&#44; Servicio de Pediatr&#237;a&#44; Hospital Universitario Miguel Servet&#44; Zaragoza&#44; Espa&#241;a"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Unidad de Neonatolog&#237;a&#44; Servicio de Pediatr&#237;a&#44; Complexo Hospitalario Universitario de A Coru&#241;a &#40;CHUAC&#41;&#44; Sergas&#44; A Coru&#241;a&#44; Espa&#241;a"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Medicamentos off-label y sin licencia en neonatolog&#237;a"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">At present&#44; a significant proportion of neonates admitted to neonatal intensive care units &#40;NICUs&#41; receive off-label or unlicensed drugs&#44; mainly due to the scarcity of evidence on drug efficacy and safety in the neonatal period&#46; In Spain&#44; a recent study in a level IIIC NICU conducted by Sucasas-Alonso et al&#46; found that 22&#46;5&#37; of prescriptions were off-label and 8&#37; unlicensed&#44; and that as many as 59&#46;5&#37; of the patients received at least one prescription under one of these conditions&#46;<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Unlicensed</span> refers to use of unauthorised drugs&#44; drugs contraindicated in the neonatal period&#44; imported drugs or formulations compounded in the pharmacy&#44; the latter of which account for a large part of the variability of unlicensed drug prescription found between studies conducted in different countries&#46; <span class="elsevierStyleItalic">Off-label</span> refers to the use of authorised drugs under conditions other than those detailed in the summary of product characteristics approved by the competent regulatory agent in terms of age&#44; indication&#44; dosage&#44; interval between doses or the route of administration&#46; The substantial variability in off-label prescription is due to the criterion used to define it&#59; thus&#44; Gei&#223;ler et al&#46; reported a proportion of off-label prescription of 39&#46;2&#37; in one NICU in 2014 considering exclusively the age criterion&#44;<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> whereas a multicentre study conducted in Italy by Cuzzolin and Agostino found a proportion of off-label prescription of 59&#46;5&#37; over the total prescriptions taking into account criteria in addition to age&#44; such as the indication&#44; dose&#44; dose schedule&#44; route of administration and duration of treatment&#46;<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> In a study published in the current issue of <span class="elsevierStyleSmallCaps">Anales de Pediatr&#237;a</span>&#44; Lima-Costa et al&#46; analysed off-label and unlabelled prescriptions in a NICU in Brazil based on the criteria established by 2 agencies&#58; the National Health Surveillance Agency &#40;ANVISA&#41; of Brazil and the Food and Drug Administration &#40;FDA&#41; of the United States&#46;<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> They found a higher frequency of unlicensed prescription with the application of the FDA criteria &#40;24&#46;6 vs 17&#46;2&#37;&#59; <span class="elsevierStyleItalic">P</span>&#8239;<span class="elsevierStyleItalic">&#60;</span>&#8239;&#46;01&#41;&#46; However&#44; when it came to off-label prescription&#44; the frequency was lower applying the criteria of the FDA &#40;49&#46;3 vs 52&#46;6&#59; <span class="elsevierStyleItalic">P</span>&#8239;<span class="elsevierStyleItalic">&#60;</span>&#8239;&#46;01&#41;&#44; as this agency is more specific in regard to the ages and indications for which use is authorised&#46; The agreement analysis found the greatest disparities in age and indication criteria&#44; especially for drugs acting on the cardiovascular system and the central nervous system&#46; This study contributes new evidence on the issue of unapproved drug prescription in neonatology&#46;</p><p id="par0015" class="elsevierStylePara elsevierViewall">Pharmacological treatment in neonates is affected by the immaturity of the hepatic clearance systems and renal function in this population&#44; which differs from other age groups not only in pharmacokinetics&#44; but also in pharmacodynamics&#46; This is particularly relevant in the NICU setting due to the underlying conditions that affect critically ill neonates and the high proportion of patients born preterm or small for gestational age&#46; Thus&#44; more paediatric and neonatal studies are required to achieve a reduction in off-label and unlicensed prescription&#46; This was the main objective of the legislation introduced in the European Union in 2007&#58; to reduce the use of off-label drugs in the paediatric age group and to increase the clinical evidence in this population to improve the safety of pharmacotherapy&#46; Some of the measures adopted to this end were the extension of patents for paediatric drugs and the establishment of public funding programmes to facilitate research outside the pharmaceutical industry&#46; However&#44; as the study by Gei&#223;ler et al&#46; demonstrates&#44; there were no changes in the patterns of off-label prescription between 2004 and 2014 associated with the legislation introduced in the European Union in 2007&#44; of which a very clear example is the fact that despite changes in regulation&#44; 100&#37; of neonates born preterm before 28 weeks&#8217; gestation received at least 1 off-label or unlicensed drug&#46;<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> The number of drugs licensed for use in newborns continues to be small&#44; for while European law mandates that trials include this population in the authorization process for any new drugs&#44; this obligation does not extend to drugs that are already marketed to which&#44; consequently&#44; the protection of the patent does not apply&#44; providing little incentive for pharmaceutical companies to change the situation&#44; as future profits would be relatively small relative to the costs of the research that would be required&#46;</p><p id="par0020" class="elsevierStylePara elsevierViewall">In the current issue of <span class="elsevierStyleSmallCaps">Anales de Pediatr&#237;a</span>&#44; Pi&#241;eiro P&#233;rez et al&#46;&#44; on behalf of the Committee on Medicines of the Asociaci&#243;n Espa&#241;ola de Pediatr&#237;a &#40;Spanish Association of Pediatrics&#44; AEP&#41;&#44; reflect on some of the theoretical&#44; legal and practical aspects of unapproved prescription in paediatrics&#46; We believe that the concise yet rigorous exposition by the authors&#44; in the form of questions and answers&#44; will contribute to a clearer understanding to the very important subject of drug prescription in paediatrics&#44; particularly in neonatal care and neonatal intensive care units&#46;<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">The fact that some drugs go from being considered off-label to being authorised and vice versa evinces that authorization does not necessarily imply that more evidence is available on those drugs&#46; This is particularly evident in older drugs&#44; for which fewer requirements needed to be met for authorization compared to current requirements&#46; In any case&#44; it is obvious that off-label prescription is neither illegal nor inappropriate and is often a decision based on years of clinical experience and a lack of alternative drugs stemming from the low availability of adequate drugs currently licensed&#46; Nevertheless&#44; this carries an increased risk for neonates&#44; as evinced by the higher frequency of adverse drug reactions and medication errors in this age group&#46;</p><p id="par0030" class="elsevierStylePara elsevierViewall">The number of off-label prescriptions becomes significantly smaller if the criteria used to define them includes&#44; in addition to those of regulatory agencies&#44; the criteria of other databases&#44; such as the databases available in Spain in the field of paediatrics &#40;<span class="elsevierStyleItalic">Pediam&#233;cum</span>&#44; launched by the Committee on Medicines of the AEP in 2012&#41; or for the general population &#40;<span class="elsevierStyleItalic">Bot Plus</span>&#44; created by the General Council of Boards of Pharmacy of Spain&#41;&#44; which provide standardised and updated information on medicines&#46; Similarly&#44; Cuzzolin and Agostino showed that taking as reference the guidelines developed by the Neonatal Pharmacotherapy Study Group of the Italian Society of Neonatology&#44; only one fourth of prescriptions deviated from the recommendations&#44; compared to a proportion of off-label or unlicensed prescription of 73&#46;5&#37; based on the criteria of regulatory agencies&#46;<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> This demonstrates that there is a marked discrepancy between the general indications included in the summary of product characteristics and the recommendations given taking into account patient characteristics and indications&#46; In neonatal care&#44; this is particularly frequent in antimicrobial prescription&#46;</p><p id="par0035" class="elsevierStylePara elsevierViewall">In our opinion&#44; the solution of this problem requires the development of policies providing incentives for research in the neonatal age group&#46; However&#44; while we await further and improved evidence allowing a reduction in unapproved drug prescription&#44; efforts should be made to achieve greater homogeneity in the information available on pharmacological agents used in the neonatal population&#46;</p></span>"
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0030">Please cite this article as&#58; &#193;vila-&#193;lvarez A&#46; Medicamentos off-label y sin licencia en neonatolog&#237;a&#46; An Pediatr &#40;Barc&#41;&#46; 2021&#59;94&#58;127&#8211;128&#46;</p>"
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:5 [
            0 => array:3 [
              "identificador" => "bib0005"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Uso de medicamentos en condiciones no aprobadas en cuidados intensivos neonatales"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46; Sucasas-Alonso"
                            1 => "A&#46; &#193;vila-&#193;lvarez"
                            2 => "M&#46; Combarro-Eiriz"
                            3 => "C&#46; Mart&#237;nez-Roca"
                            4 => "P&#46; Y&#225;&#241;ez-G&#243;mez"
                            5 => "A&#46; Codias-L&#243;pez"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "An Pediatr &#40;Barc&#41;"
                        "fecha" => "2019"
                        "volumen" => "91"
                        "paginaInicial" => "237"
                        "paginaFinal" => "243"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0010"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Drug utilization and off-label use on a German Neonatal Intensive Care Unit&#58; A retrospective cohort study and 10-year comparison"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "C&#46; Gei&#223;ler"
                            1 => "C&#46; Schulze"
                            2 => "S&#46; Botzenhartdt"
                            3 => "W&#46; Rascher"
                            4 => "A&#46; Neubert"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "tituloSerie" => "Pharmacy &#40;Basel&#41;"
                        "fecha" => "2020"
                        "volumen" => "8"
                        "paginaInicial" => "173"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0015"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Off-label and unlicensed drug treatments in Neonatal Intensive Care Units&#58; an Italian multicentre study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "L&#46; Cuzzolin"
                            1 => "R&#46; Agostino"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s00228-015-1962-4"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur J Clin Pharmacol"
                        "fecha" => "2016"
                        "volumen" => "72"
                        "paginaInicial" => "117"
                        "paginaFinal" => "123"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26490354"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0020"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Evaluaci&#243;n comparativa de la prescripci&#243;n de medicamentos off-label y sin licencia en neonatos&#58; FDA versus directrices brasile&#241;as"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "H&#46;T&#46;M&#46; Lima-Costa"
                            1 => "P&#46;K&#46; do Vale Bezerra"
                            2 => "J&#46;E&#46; Chaves-Cavalcanti"
                            3 => "T&#46;X&#46; Costa"
                            4 => "F&#46;E&#46; Medeiros-Fernandes"
                            5 => "R&#46; Randall-Martins"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "An Pediatr &#40;Barc&#41;"
                        "fecha" => "2021"
                        "volumen" => "94"
                        "paginaInicial" => "153"
                        "paginaFinal" => "160"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0025"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Medicamentos fuera de ficha t&#233;cnica en pediatr&#237;a"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "R&#46; Pi&#241;eiro P&#233;rez"
                            1 => "E&#46; N&#250;&#241;ez Cuadros"
                            2 => "B&#46; Rodr&#237;guez Marrod&#225;n"
                            3 => "R&#46; Escrig Fern&#225;ndez"
                            4 => "M&#46;A&#46; Gil Lemus"
                            5 => "S&#46; Manzano Blanco"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "An Pediatr &#40;Barc&#41;"
                        "fecha" => "2021"
                        "volumen" => "94"
                        "paginaInicial" => "188&#46;e1"
                        "paginaFinal" => "188&#46;e9"
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/23412879/0000009400000003/v1_202103020834/S2341287921000120/v1_202103020834/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "25501"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Editorial"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/23412879/0000009400000003/v1_202103020834/S2341287921000120/v1_202103020834/en/main.pdf?idApp=UINPBA00005H&text.app=https://analesdepediatria.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341287921000120?idApp=UINPBA00005H"
]
Article information
ISSN: 23412879
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 7 9 16
2024 October 44 33 77
2024 September 54 31 85
2024 August 51 44 95
2024 July 33 25 58
2024 June 40 26 66
2024 May 49 46 95
2024 April 23 34 57
2024 March 31 21 52
2024 February 31 33 64
2024 January 33 20 53
2023 December 21 18 39
2023 November 39 30 69
2023 October 32 20 52
2023 September 38 26 64
2023 August 25 22 47
2023 July 43 31 74
2023 June 50 38 88
2023 May 38 28 66
2023 April 18 16 34
2023 March 33 17 50
2023 February 27 12 39
2023 January 16 15 31
2022 December 43 27 70
2022 November 46 22 68
2022 October 43 41 84
2022 September 27 23 50
2022 August 35 41 76
2022 July 28 37 65
2022 June 24 26 50
2022 May 41 38 79
2022 April 20 27 47
2022 March 45 49 94
2022 February 34 30 64
2022 January 25 24 49
2021 December 28 36 64
2021 November 31 35 66
2021 October 94 79 173
2021 September 37 32 69
2021 August 39 52 91
2021 July 31 37 68
2021 June 31 35 66
2021 May 40 46 86
2021 April 168 65 233
2021 March 195 81 276
2021 February 52 30 82
Show all

Follow this link to access the full text of the article

Idiomas
Anales de Pediatría (English Edition)
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?